RP3-340N1.2 Knockdown Suppresses Proliferation and Migration by Downregulating IL-6 in Non-Small Cell Lung CancerOA
Objectives:Non-small cell lung cancer(NSCLC)remains a leading cause of cancer-related mortality,with limited understanding of lncRNA-driven mechanisms in tumor progression.This study aimed to identify differentially expressed lncRNAs in NSCLC tissues and elucidate the functional role of the significantly upregulated RP3-340N1.2 in promoting malignancy.Methods:RNA sequencing was used to screen dysregulated lncRNAs.RP3-340N1.2 was functionally characterized via gain/loss-of-function assays in NSCLC cells,assessing proliferation,migration,and macrophage polarization.Mechanisms of interleukin 6(IL-6)regulation were explored using cytokine profiling,Actinomycin D assays,and RNA Immunoprecipitation(RIP)assays to study RP3-340N1.2 interactions with zinc finger CCCH-type containing 12A(ZC3H12A)and IL-6 mRNA.Results:RP3-340N1.2 was upregulated in NSCLC tissues and cells.Functional assays demonstrated that RP3-340N1.2 knockdown suppressed NSCLC cell proliferation/migration and reduced macrophage polarization toward tumor-associated phenotypes.Mechanistically,RP3-340N1.2 knockdown promoted IL-6 mRNA degradation,as supported by reduced IL-6 levels and accelerated mRNA decay.Further RIP assays revealed that RP3-340N1.2 interacts with ZC3H12A,an RNA-binding protein previously reported to degrade IL-6 mRNA,and that RP3-340N1.2 knockdown enhanced ZC3H12A binding to IL-6 mRNA.Consequently,RP3-340N1.2 knockdown in carcinoma cells attenuated IL-6-mediated tumor-promoting effects,including tumor cell proliferation and migration.Importantly,these effectswere observed not only in a direct carcinoma cell culturing system but also when carcinoma cells were exposed to conditioned medium from co-culturing RP3-340N1.2-knockdown tumor cells andmacrophages.Conclusion:RP3-340N1.2 drivesNSCLC malignancy by stabilizing IL-6 mRNA;its inhibition offers a potential therapeutic strategy to disrupt tumor-promoting interactions.
Hang Zhang;Meng-yuan Chu;Guohui Lv;You-JieLi;Xuhang Liu;Fei Jiao;Yun-Fei Yan
Department of Biochemistry and Molecular Biology,Binzhou Medical University,Yantai,264003,ChinaDepartment of Biochemistry and Molecular Biology,Binzhou Medical University,Yantai,264003,ChinaDepartment of Biochemistry and Molecular Biology,Binzhou Medical University,Yantai,264003,ChinaDepartment of Biochemistry and Molecular Biology,Binzhou Medical University,Yantai,264003,ChinaSchool of Science,Xi’an Jiaotong-Liverpool University,Suzhou,215123,ChinaDepartment of Biochemistry and Molecular Biology,Binzhou Medical University,Yantai,264003,ChinaDepartment of Biochemistry and Molecular Biology,Binzhou Medical University,Yantai,264003,China
医药卫生
RP3-340N1.2interleukin 6(IL-6)zinc finger CCCH-type containing 12A(ZC3H12A)non-small cell lung cancertumor associated macrophage
《BIOCELL》 2026 (1)
P.212-231,20
supported by the National Natural Science Foundation of China(No.81702296).
评论